Lung Cancer – Geoffrey Oxnard, MD, and Robert Figlin, MD, discuss integrating liquid biopsies into lung cancer care
What to Look for at ASH 2019
Nov 26, 2019
During a pre-meeting webinar devoted to ASH 2019, experts highlighted important advances and practice-changing studies to be presented in Orlando, FL, December 7-...
Third-Line Treatment in Metastatic Colorectal Cancer Po...
Oct 07, 2019
Targeted oral tyrosine kinase inhibitors (TKIs) have an established role in third-line treatment of metastatic colorectal cancer (mCRC), but an expert outlined an...
ESMO Opens with Survival Benefits from Long-Term Data i...
Sep 30, 2019
The 2019 European Society of Medical Oncology (ESMO) opened with a series of trials with positive overall survival (OS) data. Generally considered the gold standa...
Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to Ontellitrac and a customized email alert system summarizing the most recent oncology-specific information available.
Learn MoreThe Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.
Learn MoreOriginal articles, thought leader interviews, and other resources covering testing, patient selection and treatment options in AML
Supported by:
We explore the scope of the escalating cost of cancer care, discuss the factors that contribute to the total cost of cancer care, and provide resources to help us all understand the facts regarding the cost of cancer care.
Sponsored by:
Orlando, FL
San Antonio, TX
San Francisco, CA
New Orleans, LA
Orlando, FL
Washington, D.C.
St. Gallen, Switzerland
Indianapolis, IN
San Diego, CA
Chicago, IL
Denver, CO
Date | Company and Product |
---|---|
Dec 07 | Roche , |
Dec 07 | Celgene , |
Dec 09 | Roche , |
Dec 09 | Celgene / bluebird bio, |
Dec 10 | Celgene / Bluebird Bio, |